In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Teva sets up South Korean joint venture with Handok

Executive Summary

Teva Pharmaceutical Industries Ltd. has set up a joint venture with Handok Pharmaceuticals Co. Ltd. (prescription and OTC products, and glucose monitoring systems) to market branded generic drugs, including specialty therapeutics and biosimilars, in South Korea.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register